Pulmonary Arterial Hypertension-Specific Therapy for Atrial Septal Defects with Severe Pulmonary Arterial Hypertension

Abstract excerpt

<title>Abstract</title> <p>Background Pulmonary arterial hypertension (PAH) complicates a subset of patients with atrial septal defects (ASD). Although patients with ASD-PAH and high pulmonary vascular resistance (PVR) generally do not benefit, those who demonstrate a favorable response to PAH-specific therapy, particularly a PVR of < 5 Wood units (WU) post-treatment, may be considered for shunt closure. We aime...

Topics

Open a Topic to create a Post that cites this publication.

• Biomedical Research
• Cardiology
• Developing Countries
• Early Diagnosis
• Familial Primary Pulmonary Hypertension
• Hypertension, Pulmonary
• International Cooperation
• Magnetic Resonance Angiography

Identifiers and source

Literature Corpus work

7a2b9123-5b79-5efa-a33b-334bfd464b59

DOI

10.21203/rs.3.rs-8754390/v1